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Abstract
Background: Coronary artery disease (CAD) is associated with cognitive decrements and
risk of later dementia, but it is not known if shared genetic factors underlie this associ-
ation. We tested whether polygenic risk for CAD was associated with cognitive ability in
community-dwelling cohorts of middle-aged and older adults.
Methods: Individuals from Generation Scotland: Scottish Family Health Study (GS:SFHS,
N ¼ 9865) and from the Lothian Birth Cohorts of 1921 (LBC1921, N¼ 517) and 1936
(LBC1936, N¼1005) provided cognitive data and genome-wide genotype data. Polygenic
risk profile scores for CAD were calculated for all of the cohorts using the largest avail-
able genome-wide association studies (GWAS) data set, the CARDIoGRAM consortium
(22 233 cases and 64 762 controls). Polygenic risk profile scores for CAD were then tested
for their association with cognitive abilities in the presence and absence of manifest car-
diovascular disease.
Results: A meta-analysis of all three cohorts showed a negative association between
CAD polygenic risk and fluid cognitive ability (b¼0.022, P¼0.016), verbal intelligence
(b¼0.024, P¼0.011) and memory (b¼0.021, P¼ 0.028).
Conclusions: Increased polygenic risk for CAD is associated with lower cognitive ability
in older adults. Common genetic variants may underlie some of the association between
age-related cognitive decrements and the risk for CAD.
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VC The Author 2016. Published by Oxford University Press on behalf of the International Epidemiological Association 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
International Journal of Epidemiology, 2016, 1–8
doi: 10.1093/ije/dyv354
Original article
 Int. J. Epidemiol. Advance Access published January 28, 2016
 at Edinburgh U
niversity on February 1, 2016
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
Introduction
Age-related cognitive decline is an important aspect of
health in older people. Accelerated cognitive ageing is asso-
ciated with greater mortality and morbidity, less independ-
ence, lower quality of life and increased dementia risk.1
Since dementia is a substantial and growing burden on age-
ing populations,2 it is important to understand the mech-
anisms underpinning cognitive ability and ageing.
Some cognitive abilities decline on average as people
grow older, including aspects of memory, speed of thinking
and abstract reasoning.1 Age-related cognitive decline
shows substantial variation in the population3,4 and this
has spurred attempts to discover the factors influencing
cognitive abilities in later life. Genetic and environmental
risk factors both make a substantial contribution to peo-
ple’s differences in their level of cognitive ability. Twin
studies suggest that the heritability of cognitive ability is
above 50% in adulthood, including in older age.5–7
Genome-wide association studies (GWAS) suggest that
around one-third of the variation in cognitive ability is ac-
counted for by common genetic variants.8,9
A proportion of the variation in cognitive ability levels
is probably due to disease states. Coronary artery disease
(CAD) is one type of cardiovascular disease (CVD) ro-
bustly associated with reduced cognitive ability.10–15 It
tends to be assumed that the direction of the causation be-
tween CAD and cognitive ability is that more CAD leads
to lower cognitive ability. There is considerable evidence
indicating the reverse direction also, whereby lower cogni-
tive ability in childhood represents a risk factor for CAD
and is associated with higher morbidity and mortality for
CAD.16,17 Whereas there is a substantial environmental
contribution to CAD, family and twin studies suggest that
CAD is also substantially heritable, with approximately
40% to 50% of its susceptibility being accounted for by
genetic factors.18 Based on a heritability of 40%, recent
GWAS studies have shown that 45 confirmed CAD suscep-
tibility loci explained 6% of the additive genetic variance
for CAD, which increased to 10.6% after the addition of
104 nominally associated variants.19
In summary, CAD and cognition are correlated phenotyp-
ically, and population variation in each is caused by genetic
and environmental factors. Luciano et al.20 showed that
some associations between risk factors for CVD and cogni-
tive ability are explained by genetic factors. Therefore, it is
possible that the association between CAD and cognitive
ability may in part be due to shared genetic variation; that is,
some genetic risk factors might confer risk of both CAD and
lower cognitive ability level. In order to test whether there is
a genetic correlation between CAD and cognitive ability, co-
horts consisting of cognitively healthy individuals with both
genome-wide genotyping and cognitive data are required.
Because of their phenotypic correlation and the herit-
able and polygenic nature of both CAD and cognitive abil-
ity, we hypothesized that these traits have shared genetic
causes. We tested the hypothesis using a polygenic risk
profiling approach,21 using the Lothian Birth Cohorts
(LBCs) and the Generation Scotland: Scottish Family
Health Study Cohort (GS:SFHS) in the presence and ab-
sence of manifest CVD.
Methods
Cohorts and cognitive measures
GS:SFHS
GS:SFHS is a recently available population-based cohort of
over 21 000 people.22,23 Genome-wide single nucleotide
polymorphism (SNP) data were ascertained for 9865 indi-
viduals, 5790 female and 4075 male, with a mean (stand-
ard deviation; SD) age of 52.2 (13.6) years. Details of
GS:SFHS are provided in the Supplementary material
(available as Supplementary data at IJE online) and the
derived cognitive measures are shown in Table 1. In short,
the cohort included measures of verbal intelligence
(N¼ 9697), memory (N¼ 9748), verbal fluency
(N¼ 9753) and processing speed (N¼ 9732). A derived
measure of fluid cognitive ability (N¼ 9630) was obtained
through a principal component analysis (PCA) of the meas-
ures for memory, verbal fluency and processing speed, and
extracting the first unrotated principal component.
Key Messages
• Coronary artery disease is associated with lower cognitive ability.
• This study examines the association between polygenic risk for coronary artery disease and cognitive ability in a
large sample (N¼11 387).
• The findings imply a shared genetic architecture between coronary artery disease and lower cognitive ability.
• Identifying associated pathways may provide novel drug targets for these common conditions.
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LBC1921 and LBC1936
The LBCs of 1921 and 1936 are longitudinal studies pro-
viding lifelong cognitive data between the ages of 11 and
79, and genome-wide SNP data for a total of 1522 older
individuals (LBC1921¼ 517 individuals, 302 female and
215 male, LBC1936¼ 1005 individuals, 496 female and
509 male).24,25 The Lothian Birth Cohorts were origin-
ally identified through contacting individuals living in
the Edinburgh area of Scotland (Lothian) who were born
in 1921 or 1936 and might therefore have taken part in
the Scottish Mental Surveys (SMS) at age about 11 years
in 1932 or 1947, respectively. In these surveys, almost
every child born in those years and attending school in
Scotland completed the Moray House Test No. 12
(MHT) assessment of general intelligence. All partici-
pants of both LBCs completed an additional cognitive
test battery around the ages of 79 and 83 in LBC1921
and age 70 in LBC1936, including a measure of verbal
intelligence (total N¼ 1515). Derived measures of mem-
ory (total N¼ 1477), processing speed (total N¼ 1253)
and fluid cognitive ability (total N¼ 1491) were ob-
tained through a PCA and extracting the first unrotated
principal component. Details of the LBCs and derived
cognitive measures are shown in the Supplementary ma
terial (available as Supplementary data at IJE online)
and in Table 1.
Genotyping
DNA extracted from venous blood from the participants
was genotyped at the Wellcome Trust Clinical Research
Facility using the Illumina HumanOmniExpressExome-8
v1.0 DNA Analysis Beadchip and Infinium chemistry
(GS:SFHS),26,27 and the Illumina 610-Quadv1 whole-gen-
ome SNP array (LBC’s). The sample collection, quality
control and genotyping process is described elsewhere in
more detail.8,23 Four (five for GS:SFHS) MDS components
were calculated and extracted using the SNP data set to
control for population stratification. Scree plots of the first
10 MDS components for population stratification in
GS:SFHS and the first four in both LBCs are shown in
Supplementary Figure 1a–c (available as Supplementary
data at IJE online).
Creating CAD polygenic risk scores
The method to create polygenic risk scores (PGRS) has
been described previously.21 In summary, this method cal-
culates SNP effect sizes from published genetic association
data and calculates the genome-wide weighted sum of the
alleles that an individual carries. This sum, the polygenic
risk score, then serves as an index of the genetic load for a
specific disease. Summary statistics from the
CARDIoGRAM consortium (22 233 cases and 64 762
Table 1. Cognitive abilities derived from the cognitive test battery of GS:SFHS, LBC1921 and LBC1936
GS:SFHS LBC1921 LBC1936
Fluid cognitive ability Logical Memory†
Verbal Fluency*
Digit Symbol-Coding*
Moray House Test
Raven’s Standard Progressive Matrices‡
Total Logical Memory‡
Verbal Fluency
Digit Span Backwards†
Matrix Reasoning*
Letter-Number Sequencing*
Block Design*
Symbol Search*
Digit Symbol*
Verbal intelligence Mill Hill Vocabulary Test National Adult Reading Test National Adult Reading Test
Memory Logical Memory† Total Logical Memory‡ Logical Memory I Total Recall†
Logical Memory Ii Delayed Total Recall†
Spatial Span Forward†
Spatial Span Backward†
Verbal Paired Associates I & II†
Letter-Number Sequencing*
Digit Span Backwards*
Processing speed Digit Symbol-Coding* Digit Symbol*
4-Choice Reaction Time mean
Inspection Time mean
Digit Symbol*
Choice Reaction Time mean
Simple Reaction Time mean
Inspection Time
Symbol Search
Test references are shown in the supplemental methods.
†Wechsler Memory Scale-III.
*Wechsler Adult Intelligence Scale-III.
‡Wechsler Memory Scale-Revised.
International Journal of Epidemiology, 2016, Vol. 0, No. 0 3
 at Edinburgh U
niversity on February 1, 2016
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
controls) were used to create the CAD PGRS. Details of
the methods used by CARDIoGRAM can be found else-
where.28 The training sample data results for each SNP
were thresholded at cut-offs of 0.01, 0.05, 0.1, 0.5 and 1.
After linkage disequilibrium pruning (based on r2>0.25
within a 200-SNP sliding window), the five resulting SNP
sets were used to construct a risk profile for the subjects in
GS:SFHS, LBC1921 and LBC1936, using the cumulative
sum of each SNP allele dose multiplied by the log of the
odds ratio derived from CARDIoGRAM. Raw genotype
data were used to create the risk scores for both LBCs and
GS:SFHS. The number of SNPs included in each threshold
in the three cohorts can be found in Supplementary Table
1 (available as Supplementary data at IJE online).
Throughout the paper, only the data using the cut-off of
0.5 will be reported as this threshold has shown to be the
most predictive threshold in a large independent sample
(UK Biobank, n¼ 112 151, Supplementary Table 2, avail-
able as Supplementary data at IJE online).
Statistical analysis
All statistical analyses were conducted in the R statistical
software package.29 Point-biserial correlation coefficients
were calculated between self-reported CVD and the cogni-
tive phenotypes. At all five SNP thresholds, linear regression
models were created between CAD PGRS and self-reported
CVD, as proof of principle, and the cognitive phenotypes,
adjusting for the four MDS components for population
stratification, age and sex in both LBC1921 and LBC1936.
The GS:SFHS models were also adjusted for family
structure by fitting a univariate linear mixed model which
estimates the genetic and environmental variance, using
the ASReml program.30 The inverse of a relationship ma-
trix was created by using pedigree kinship information to
fit the family structure as a random effect. The cognitive
scores were used as the dependent variable and age, sex,
the five MDS components and the PGRS were used as
fixed effects. Wald’s conditional F-test was used to calcu-
late P-values for the fixed effects. Additional analyses were
performed adjusting the fluid cognitive ability models for
verbal intelligence and the verbal intelligence models for
fluid cognitive ability.
An analysis by age group (<40 years, 40–60 years,
>60 years) in GS:SFHS was performed to test if CAD
PGRS had different associations with cognition in different
age groups. An analysis excluding participants with self-re-
ported CVD was performed to test if any associations with
cognitive ability were being driven by participants with
CVD.
A meta-analysis, using the meta package, of the results
across studies was then conducted in order to synthesize
the findings for maximum statistical power and to check
for heterogeneity. A fixed-effects model was used in which
the standardized regression coefficients were weighted by
the inverse of their squared standard error and pooled to
provide a summary estimate across both cohorts, based on
the method of the DerSimonian-Laird estimator.31 We
tested for the presence and magnitude of between-study
heterogeneity using Cochran’s Q and the I2 statistic,
respectively.32
To test whether different CAD SNPs are contributing to
different cognitive traits, a linear regression was conducted
between 25 (of 45) CAD SNPs that were available in the
largest data set (GS:SFHS), adjusting for age, sex and five
MDS components for population stratification.
Results
A positive CVD history was observed in 30.2 % of
LBC1921 (n¼ 156), 24.6 % of LBC1936 (n¼ 247) and 4.7
% of GS:SFHS (n¼ 471). All cognitive traits were approxi-
mately normally distributed, with outliers>6 3.5 SDs from
the mean excluded. There were many (9 of 15) small point-
biserial correlations between self-reported history of CVD
and lower scores for the cognitive phenotypes in the larger
GS:SFHS and LBC1936 cohorts, but not in LBC1921,
though the latter had similar effect sizes (Table 2).
Phenotypic correlations between the different cognitive abil-
ity traits in each cohort can be found in Supplementary
Table 3a–c (available as Supplementary data at IJE online).
Correlations between the polygenic risk scores in each co-
hort can be found in Supplementary Table 4a–c (available
as Supplementary data at IJE online).
A fixed-effects meta-analysis of the cognitive pheno-
types in all three cohorts showed that CAD polygenic risk
was positively associated with self-reported CVD at all
SNP inclusion thresholds (Table 3, Figure 1). CAD
Table 2. Phenotypic correlations (point-biserial) for self-
reported cardiovascular disease and each of the cognitive
traits for the three cohorts
Self-reported cardiovascular disease
GS:SFHS LBC1921 LBC1936
VI 0.01 0.08 0.07*
Memory 0.07** 0.07 0.10**
PS 0.16** 0.14* 0.14**
VF 0.02* 0.08 0.05
Gfluid 0.12** 0.05 0.13**
VI, verbal intelligence; PS, processing speed; VF, Verbal Fluency test; Gfluid,
fluid cognitive ability.
*P< 0.05; **P< 0.005.
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polygenic risk was associated with fluid cognitive ability
(b¼0.0213, P¼ 0.0195), with verbal intelligence
(b¼0.0238, P¼0.0107) and with memory
(b¼0.0186, P¼ 0.0461). No heterogeneity was reported
except for CVD history at a threshold of P<0.01
(I2¼ 72.7%, P¼ 0.03) (Supplementary Table 5, available
as Supplementary data at IJE online).
Individual analysis of the three cohorts showed that
CVD status was associated with CAD PGRS in GS:SFHS
(b¼ 0.202, P¼0.0013) and LBC1921 (b¼ 0.231,
P¼ 0.0225). No association was found between CVD sta-
tus and CAD PGRS in LBC1936 and LBC1921
(Supplementary Tables 6 and 8, available as
Supplementary data at IJE online).
Table 3. Effect size and significance of meta-analysis correlations between CAD polygenic risk scores and cognitive abilities or
self-reported history of cardiovascular disease
CAD genetic risk scores:
SNPs with P-values <
Fluid cognitive ability Verbal intelligence Memory Processing speed IQ age 11 CVD history
n¼11121 n¼11121 n¼11225 n¼10985 n¼1408 n¼7930
1 b 0.0220 0.0237 0.0205 0.0063 0.0253 0.1806
z 2.41 2.53 2.19 0.74 0.081 4.15
P-value 0.0161 0.0113 0.0284 0.4567 0.3444 3.333 105
0.5 b 0.0213 0.0238 0.0186 0.0049 0.0216 0.1737
z 2.34 2.55 1.99 0.59 0.807 4.00
P-value 0.0195 0.0107 0.0461 0.559 0.4197 6.403 105
0.1 b 0.0072 0.0160 0.0114 0.0007 0.0287 0.1818
z 0.79 1.71 1.22 0.09 1.07 4.20
P-value 0.429 0.0865 0.2207 0.9313 0.2843 2.703 105
0.05 b 0.0014 0.0135 0.0077 0.0070 0.0019 0.1341
z 0.16 1.45 0.82 0.83 0.07 3.12
P-value 0.8759 0.1477 0.411 0.406 0.9429 0.0018
0.01 b 0.0003 0.0128 0.0135 0.0078 0.003 0.1006
z 0.03 1.38 1.44 0.92 0.1137 2.33
P-value 0.9742 0.1716 0.1489 0.3571 0.9095 0.0194
Effects with P< 0.05 are shown in bold.
CAD, coronary artery disease; CVD history, history of cardiovascular disease; b, standardized regression coefficient.
* * * *
* *
-0.05
0.00
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Figure 1. Meta-analysis of associations between coronary artery disease polygenic risk and cognitive traits at five SNP thresholds. Plot shows
estimates with 95% confidence intervals; results with P-values below 0.05 are indicated by an asterisk.
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In GS:SFHS, CAD PGRS showed an association with
the Mill Hill Vocabulary (MHV) test (b¼0.03,
P¼ 0.004), with Memory (b¼0.02, P¼0.035) and with
fluid cognitive ability (b¼0.02, P¼0.020). No associ-
ations were found for the other cognitive phenotypes. The
direction of effect for all associations of the cognitive
phenotypes with CAD PGRS was negative and occurred in
the proposed direction of the hypothesis: greater CAD
PGRS is associated with lower cognitive test scores. A sub-
set without individuals with self-reported CVD showed
comparable results (Supplementary Table 6). No associ-
ations were found for the age group below 40 years
(n¼ 1831), or the group between 40 and 60 years
(n¼ 5204). In the age group above 60 years (n¼ 2825)
CAD PGRS showed an association with fluid cognitive
ability (b¼0.037, P¼ 0.044), as well as verbal fluency
(VF) (b¼0.063, P¼ 0.001) (SupplementaryTable 7,
available as Supplementary data at IJE online).
Additional analyses adjusting the verbal intelligence
models for fluid cognitive ability showed that verbal intelli-
gence remains associated with CAD polygenic risk
(b¼0.009, P¼ 0.29). Fluid cognitive ability is not associ-
ated with CAD polygenic risk after adjusting for verbal in-
telligence (b¼0.02, P¼ 0.03). No associations were
found between CAD PGRS and the cognitive phenotypes
in LBC1921 and LBC1936 (Supplementary Table 8, avail-
able as Supplementary data at IJE online).
In GS:SFHS, no associations were found between 25
SNPs, which passed a threshold for association for CAD,
and the cognitive traits (Supplementary Table 9, available
as Supplementary data at IJE online).
Discussion
Based on SNP associations from a large GWAS study of
CAD, PGRS were created for CAD in the three independ-
ent cohorts measuring cognition in middle to old age. CAD
PGRS was associated with CVD history at all SNP thresh-
olds in a meta-analysis of all three cohorts. This study
found widespread phenotypic associations between CVD
history and the cognitive phenotypes in GS:SFHS and
LBC1936; people with CVD tended to have lower cogni-
tive ability. In the smaller LBC1921, most associations
showed similar-sized correlation coefficients. This study
found a negative association between common genetic
variants for CAD and fluid cognitive ability in GS:SFHS
and in a meta-analysis of all three cohorts. Processing
speed and memory were the only traits showing an associ-
ation in LBC1921, the smallest of the cohorts. No associ-
ations were found in LBC1936, though the effects were in
the expected direction and comparable to the effects in
GS:SFHS. CAD PGRS were also negatively correlated with
measures of vocabulary and logical memory in GS:SFHS.
Cognitive ability tends to be lower in individuals suffer-
ing from CAD,10,33 which is supported by our results
showing a negative correlation between CVD history and
the cognitive phenotypes, and more recent studies have
demonstrated that a decline in cognitive abilities may be
seen in individuals at high risk for CAD.34 The results of
this DNA-based study suggest that the phenotypic associ-
ation between CAD and cognitive ability has some shared
genetic aetiologies. This is supported by the family-based
genetic analysis results of Luciano et al.20 on GS:SFHS.
The GS:SFHS analysis by age group showed negative as-
sociations in the age group above 60 years between CAD
PGRS and MHV, VF and fluid cognitive ability. This sug-
gests that the decline in cognitive abilities happens when
individuals reach the age where they are more at risk for
CAD. This is supported by results from the American
Heart Association, who showed that the prevalence of
CAD doubles in older individuals.35 When fitting an inter-
action term for age and CAD polygenic risk, we only found
an interaction for verbal fluency.
Although the direction of causation tends to be assumed
to be from more CAD to less cognitive capability, there is
evidence here and elsewhere to lead us to consider the re-
verse association too. It is now widely replicated that lower
general cognitive ability from childhood and young adult-
hood predicts more morbidity and mortality from CVD in
later life.17,36–39 It is notable that in the present meta-ana-
lysis, verbal intelligence was associated with CAD PGRS.
This type of vocabulary test tends to indicate peak previous
cognitive ability rather than being an indicator of cognitive
ageing. Therefore, it is possible that this result represents
some genetic confounding such that some of the same
genes result in lower vocabulary scores and more CAD.
However, we did not find an association for IQ at age 11
with CAD PGRS. It is also conceivable that the CAD
PGRS is in part picking up some of the genetic contribution
to lifetime-stable cognitive differences and that such cogni-
tive differences are associated with creating lifestyles and
environments that are more or less conducive to CAD, as
we discuss elsewhere.16,40
Fluid cognitive ability and verbal intelligence are mod-
erately correlated with each other (r¼ 0.34). The add-
itional analyses adjusting both verbal intelligence and fluid
cognitive ability for each other shows greater attenuation
for fluid cognitive ability after controlling for verbal intelli-
gence than the reverse. This could be because verbal intelli-
gence is psychometrically a more reliable measure. Also,
these results could indicate that the association with CAD
is more due to the stable trait of cognitive ability, typically
well assessed by vocabulary measures, rather than to any
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cognitive decline that might be captured by the more age-
and illness-sensitive fluid cognitive ability.
Among the study’s strengths were the large sample size
of GS:SFHS, the detailed cognitive testing of different do-
mains in the cohorts, the geographical homogeneity of the
three cohorts, the access to the results of a large meta-
analysis of GWAS studies of CAD, and the rare ability to
examine the association of CAD with cognitive ability data
in childhood and older age in both LBCs.
The present study has some limitations. The use of self-
reported CVD may have led to misclassification of CVD
conditions, causing a likely bias toward the null hypoth-
esis.33 This study is unable to test for a direction of caus-
ation between CAD and cognitive ability. Raw P-values
are presented for the PGRS associations. We acknowledge
that multiple tests were performed, but it is difficult to de-
termine the appropriate test to correct for multiple testing
because both the traits as the polygenic risk scores are
highly correlated (Supplementary Tables 3a–c and 4a–c,
available as Supplementary data at IJE online).
This study failed to replicate the associations found in
GS:SFHS between CAD PGRS and cognition in both
LBCs. The sample size of LBC1921 is substantially smaller
than the sample sizes of GS:SFHS and LBC1936; therefore
LBC1921 probably does not have enough power to detect
differences. Together with the higher mean age and the
greater comorbidity, this might explain the differences in
results. An explanation for the absence of associations in
LBC1936 might be the lack of an association between self-
reported CVD and CAD PGRS. Nevertheless, the meta-
analysis of the associations in all three cohorts supports the
overall findings and conclusion.
The present study suggests that CAD genetic risk is nega-
tively associated with cognitive ability in healthy population-
based cohorts. These findings were made in general popula-
tion cohorts and were independent of CAD pathology. These
findings suggest that CAD and cognitive ability share some
common genetic aetiology. Further annotation of the shared
genetic architecture and its associated biological pathways
may provide novel drug targets for both disorders.
Supplementary Data
Supplementary data are available at IJE online.
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